Compounds, processes for their preparation, pharmaceutical compositions containing such compounds and their use in treating therapeutic conditions, in particular conditions mediated by the action of ligands on the FP, DP, EP1, EP4, IP, DP1, FP and TP prostaglandin (PG) receptors thereby providing a general anti-inflammatory response.
化合物、制备它们的过程、含有这些化合物的制药组合物以及它们在治疗治疗性状况方面的应用,特别是介导FP、DP、EP1、EP4、IP、DP1、FP和TP
前列腺素(
PG)受体的
配体作用的情况,从而提供一般的抗炎反应。